Search
SIGA Technologies Inc
SIGAAdd to Watchlist
3.042USD
-0.108-3.42%
Market hours （ET）Quotes delayed by 15 min
217.86MMarket Cap
10.75P/E TTM
More Details of SIGA Technologies Inc Company
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
SIGA Technologies Inc Info
Ticker SymbolSIGA
Company nameSIGA Technologies Inc
IPO dateSep 09, 1997
CEONguyen (Diem)
Number of employees46
Security typeOrdinary Share
Fiscal year-endSep 09
Address31 East 62Nd Street
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10065
Phone12126729100
Websitehttps://www.siga.com/
Ticker SymbolSIGA
IPO dateSep 09, 1997
CEONguyen (Diem)
Company Executives of SIGA Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
280.49K
--
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
198.54K
--
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
138.77K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
73.75K
+22.89%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
16.88K
--
Mr. Joseph W. (Chip) Marshall, III
Mr. Joseph W. (Chip) Marshall, III
Independent Director
Independent Director
--
--
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
--
--
Dr. Gary J. Nabel, M.D., Ph.D.
Dr. Gary J. Nabel, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Holly L. Phillips, M.D.
Dr. Holly L. Phillips, M.D.
Independent Director
Independent Director
--
--
Mr. Harold E. Ford, Jr.
Mr. Harold E. Ford, Jr.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
280.49K
--
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
198.54K
--
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
138.77K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
73.75K
+22.89%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
16.88K
--
Mr. Joseph W. (Chip) Marshall, III
Mr. Joseph W. (Chip) Marshall, III
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of SIGA Technologies Inc?
The top five shareholders of SIGA Technologies Inc are: Mr. Daniel J. Luckshire
How many institutions hold shares of SIGA Technologies Inc (SIGA)?
As of 2026Q1, 396 institutions hold shares of SIGA Technologies Inc, with a combined market value of approximately 39.67M, accounting for 55.31% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 319822.00.